http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0416706-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34c531b0dce54fb192c75fd1f4f8d473
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2004-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b77794bf9877c56d8ee9629c291715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fabf1d0065a2d4fdd5283f4f6bda2cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a30553f3801003efe58c1ad7bff5385
publicationDate 2007-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0416706-A
titleOfInvention pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic containers
abstract "PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RENAL DISEASE, DISEASE OR DISORDER, PARTICULARLY IN DIABETIC PATIENTS". The present invention relates to a new use of benzazepine-N-acetic acid derivatives which contain an oxo group at position <244> relative to nitrogen and are substituted at position 3 by a 1- (carboxyalkyl) radical cyclopentylcarbonylamino and / or its biologically unstable salts and esters and / or physiologically acceptable solvates in higher mammals and particularly humans, preferably human patients having diabetes, and for the production of pharmaceutical compositions and products suitable for new treatment. The invention relates particularly to the treatment and / or prophylaxis of renal dysfunction, disease or disorder, preferably in diabetic patients, but in a broader sense also in patients with syndrome X or in particular in patients with a dysfunction. , kidney disease and / or disorder, whose patients are, in addition, hypertensive, obese, hyperglycemic and / or metabolic disorder patients.
priorityDate 2003-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19827291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420132276

Total number of triples: 23.